CXCL1 and triple-negative breast carcinoma: And we can draw conclusions from Figure 5 that CXCL1/2/3/5/6/7 are found significantly expressed in Luminal, CXCL8/11/17 in HER2 positive, and CXCL9/10/12/13/16 in triple negative breast cancer.